JPH03151900A - Method for detecting nucleic acid - Google Patents
Method for detecting nucleic acidInfo
- Publication number
- JPH03151900A JPH03151900A JP29155889A JP29155889A JPH03151900A JP H03151900 A JPH03151900 A JP H03151900A JP 29155889 A JP29155889 A JP 29155889A JP 29155889 A JP29155889 A JP 29155889A JP H03151900 A JPH03151900 A JP H03151900A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- detected
- probe
- hybrid
- immobilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 211
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 208
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 208
- 238000000034 method Methods 0.000 title claims description 60
- 239000000523 sample Substances 0.000 claims abstract description 116
- 239000007790 solid phase Substances 0.000 claims abstract description 38
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 239000011541 reaction mixture Substances 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 abstract description 23
- 125000003729 nucleotide group Chemical group 0.000 abstract description 23
- 238000002372 labelling Methods 0.000 abstract description 20
- 238000006243 chemical reaction Methods 0.000 abstract description 19
- 238000011282 treatment Methods 0.000 abstract description 10
- 230000003100 immobilizing effect Effects 0.000 abstract description 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 239000007984 Tris EDTA buffer Substances 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108050009160 DNA polymerase 1 Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- HJRIWDYVYNNCFY-UHFFFAOYSA-M potassium;dimethylarsinate Chemical compound [K+].C[As](C)([O-])=O HJRIWDYVYNNCFY-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は核酸のハイブリッド形成反応を利用した核酸の
検出方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for detecting nucleic acids using a nucleic acid hybridization reaction.
[従来の技術]
試料中に検出対象としての核酸(被検出核酸)が存在す
るか否かを検出するための方法として種々の方法が知ら
れている。[Prior Art] Various methods are known as methods for detecting whether or not a nucleic acid to be detected (nucleic acid to be detected) is present in a sample.
例えば、固相に固定した試料に標識化プローブ核酸を反
応させ、固相上での被検出核酸・ブローブ核酸ハイブリ
ッドの形成の有無をプローブ核酸に施した標識により検
出する方法、液相中で試料とプローブ核酸を反応させ、
得られた反応混合物中への被検出核酸・プローブ核酸ハ
イブリッドの形成の有無を検出する方法がある。For example, a method in which a labeled probe nucleic acid is reacted with a sample immobilized on a solid phase, and the presence or absence of formation of a target nucleic acid/probe nucleic acid hybrid on the solid phase is detected by a label applied to the probe nucleic acid; react with the probe nucleic acid,
There is a method of detecting the presence or absence of formation of a target nucleic acid/probe nucleic acid hybrid in the resulting reaction mixture.
前者の方法の一例では、まず試料を電気泳動で分画し、
ブロッティングすることによりニトロセルロースフィル
ターに試料の電気泳動パターンのレプリカを形成し、こ
のレプリカに放射性プローブ核酸を反応させる。その際
、試料中に被検出核酸が存在する場合には、被検出核酸
と放射性プローブ核酸との間にハイブリッドが形成され
る。In one example of the former method, the sample is first fractionated by electrophoresis,
By blotting, a replica of the electrophoretic pattern of the sample is formed on the nitrocellulose filter, and this replica is reacted with a radioactive probe nucleic acid. At this time, if the nucleic acid to be detected is present in the sample, a hybrid is formed between the nucleic acid to be detected and the radioactive probe nucleic acid.
その後ハイブリダイズしなかった放射性プローブ核酸を
洗浄、除去したのち、ニトロセルロースフィルター上に
形成されたハイブリッドの放射性標識領域をオートラジ
オグラフィーなどによって検出する。Thereafter, unhybridized radioactive probe nucleic acids are washed and removed, and then the radioactively labeled region of the hybrid formed on the nitrocellulose filter is detected by autoradiography or the like.
後者の方法の一例においては、溶液中で試料と放射性プ
ローブ核酸とを反応させ、試料中に被検出核酸が含まれ
ている場合に形成されるパイプリッドと未反応物とをカ
ラム処理により分離し、形成されたハイブリッド中の放
射性同位元素の標識活性を測定することで検出を行って
いる。In one example of the latter method, a sample and a radioactive probe nucleic acid are reacted in a solution, and a pipe lid that is formed when the sample contains a nucleic acid to be detected and unreacted substances are separated by column treatment. Detection is performed by measuring the labeling activity of the radioisotope in the formed hybrid.
また、カラムにプローブ核酸を固定し、試料を流して反
応させ、その後形成されたハイブリッドを抽出したのち
1本鎖に解離し、それを集めて検出する方法もある。Alternatively, there is a method in which a probe nucleic acid is immobilized on a column, a sample is caused to flow therethrough, the resulting hybrid is extracted, and then dissociated into single strands, which are then collected and detected.
[発明が解決しようとする課題]
前述の固相に固定した試料を用いる方法では、試料を大
量に浪費したり検出操作に時間がかかるうえ、固相の調
製が複雑で多くの工程を要するという欠点がある。[Problems to be Solved by the Invention] The method using a sample immobilized on a solid phase as described above wastes a large amount of sample, takes a long time to perform the detection operation, and the preparation of the solid phase is complicated and requires many steps. There are drawbacks.
また、液相で試料とプローブ核酸を反応させ、生成ハイ
ブリッドと未反応物とをカラム処理により分離する方法
においては、被検出核酸のヌクレオチド鎖が比較的短い
場合、カラム処理による分離精度が悪くなるという欠点
がある。In addition, in a method in which a sample and a probe nucleic acid are reacted in a liquid phase and the resulting hybrid and unreacted substances are separated by column treatment, if the nucleotide chain of the nucleic acid to be detected is relatively short, the separation accuracy by column treatment deteriorates. There is a drawback.
また、カラムに固定したプローブ核酸を用いる方法では
、カラムが特定の用途、すなわち、特定の核酸塩基配列
を検出する場合にしか用いることができず汎用性に欠け
る。また、複数の核酸塩基配列の検出を行う場合には、
それぞれの塩基配列に対応するプローブ核酸を作成し個
別のカラムに固定化を行なわなければならないという問
題がある。Furthermore, in the method of using a probe nucleic acid immobilized on a column, the column can only be used for a specific purpose, that is, when detecting a specific nucleic acid base sequence, and thus lacks versatility. In addition, when detecting multiple nucleobase sequences,
There is a problem in that probe nucleic acids corresponding to each base sequence must be created and immobilized on separate columns.
本発明はハイブリダイゼーション法を利用する従来の各
種検出方法における問題点を解決するために鋭意検討し
た結果なされたものであり、特定の検出対象としての核
酸の存在を速やかにかつ簡便に検出できる方法を提供す
ることを目的とする。The present invention was made as a result of intensive studies to solve the problems in various conventional detection methods using hybridization methods, and is a method that can quickly and easily detect the presence of a nucleic acid as a specific detection target. The purpose is to provide
【課題を解決するための手段]
本発明の検出方法は、
被検出核酸を含む試料と、
プローブ核酸と、
固相に結合された部分と、プローブ核酸とハイブリダイ
ズする部分とを有する固定化用核酸を用い、
a)被検出核酸・プローブ核酸・固定化用核酸ハイブリ
ッドを形成する過程と、
b)固相に結合されたハイブリッド標識を利用して被検
出核酸・プローブ核酸ハイブリッドの形成の有無を検出
する過程と
固定化用核酸を利用して得る過程と
を含むことを特徴とする。[Means for Solving the Problems] The detection method of the present invention includes a sample containing a nucleic acid to be detected, a probe nucleic acid, a portion bound to a solid phase, and a portion for immobilization that hybridizes with the probe nucleic acid. Using a nucleic acid, a) a process of forming a hybrid of a nucleic acid to be detected, a probe nucleic acid, and a nucleic acid for immobilization, and b) a process of forming a hybrid of a nucleic acid to be detected and a probe nucleic acid using a hybrid label bound to a solid phase. It is characterized in that it includes a detecting process and an obtaining process using a nucleic acid for immobilization.
本発明は生体に由来するDNAや遺伝子操作によって得
られるDNAなど各種核酸の検出に利用でき、検出対象
となる被検出核酸の種類は限定されない。The present invention can be used to detect various nucleic acids such as DNA derived from living organisms and DNA obtained by genetic manipulation, and the type of nucleic acid to be detected is not limited.
プローブ核酸としては、被検出核酸及び固定化用核酸と
特異的にハイブリダイズできる塩基配列を有する核酸で
あればどのようなものでも利用できるが、合成機で手軽
に合成できる比較的短いヌクレオチド鎖長のオリゴヌク
レオチドが利用し易い。As the probe nucleic acid, any nucleic acid can be used as long as it has a base sequence that can specifically hybridize with the nucleic acid to be detected and the nucleic acid for immobilization, but relatively short nucleotide chains that can be easily synthesized with a synthesizer can be used. oligonucleotides are readily available.
プロニブ核酸のヌクレオチド鎖長は、被検出核酸のヌク
レオチド鎖長の1/10以下とするのが好ましい。The nucleotide chain length of the pronib nucleic acid is preferably 1/10 or less of the nucleotide chain length of the nucleic acid to be detected.
なお、本発明において、プローブ核酸と被検出核酸との
二本鎖形成部に標識を施す場合、ブローブ核酸自体に標
識化に必要な要件が要求されない。In addition, in the present invention, when labeling the double-stranded portion of the probe nucleic acid and the detected nucleic acid, the requirements necessary for labeling are not required for the probe nucleic acid itself.
例えば、ニックトランスレーション法や標識酵素の結合
法を用いる標識では、標識される核酸がある程度以上の
ヌクレオチド鎖長を有する必要があるが、本発明で利用
するプローブ核酸にはこのような要件は要求されない。For example, in the case of labeling using the nick translation method or the labeling enzyme binding method, the nucleic acid to be labeled needs to have a certain length of nucleotide chain, but such a requirement is not required for the probe nucleic acid used in the present invention. Not done.
従って、入手(調製)し易く、かつ上述のように高感度
な検出を実現し得る短いヌクレオチド鎖長のものがプロ
ーブ核酸として利用できるようになる。Therefore, a short nucleotide chain that is easy to obtain (prepare) and can realize highly sensitive detection as described above can be used as a probe nucleic acid.
しかしながら、本発明において被検出核酸とプローブ核
酸の二本鎖形成部に標識が施される場合、プローブ核酸
の構成やヌクレオチド鎖長を、該二本鎖形成部の標識化
が容易であるように選択することが望ましい。However, in the present invention, when a label is applied to the double-stranded portion of the detection nucleic acid and the probe nucleic acid, the structure and nucleotide chain length of the probe nucleic acid are adjusted such that the double-stranded portion is easily labeled. It is desirable to select.
例えば、後述するような、被検出核酸とプローブ核酸の
二本鎖形成部の一方のヌクレオチド鎖をブライマーとし
て利用し、その末端からヌクレオチド鎖を伸展させ、そ
の伸展部分に標識物質を取り込ませる方法による標識化
方法で、プローブ核酸をブライマーとして利用する場合
、該二本鎖形成部が、プローブ核酸とハイブリダイズし
た被検出核酸のヌクレオチド鎖がブライマ一端部の伸展
の際の鋳型として機能できるような構成、すなわちプロ
ーブ核酸の末端伸展方向に被検出核酸のヌクレオチド鎖
が一本鎖の状態で存在する構成を有している必要がある
。For example, as described below, one nucleotide strand of the double-stranded portion of the detection nucleic acid and the probe nucleic acid is used as a primer, the nucleotide strand is extended from the end, and a labeling substance is incorporated into the extended portion. When the probe nucleic acid is used as a brimer in the labeling method, the double strand forming part is configured such that the nucleotide strand of the detected nucleic acid hybridized with the probe nucleic acid can function as a template when one end of the brimer is extended. That is, it is necessary to have a configuration in which the nucleotide chain of the nucleic acid to be detected exists in a single-stranded state in the terminal extension direction of the probe nucleic acid.
従って、このようなプローブ核酸をブライマーとして利
用するこの標識化方法の場合には、プローブ核酸の構成
やヌクレオチド鎖長を、形成される二本鎖形成部の構造
を考慮して決定するのが望ましい。Therefore, in the case of this labeling method that utilizes such a probe nucleic acid as a primer, it is desirable to determine the composition and nucleotide chain length of the probe nucleic acid in consideration of the structure of the double-stranded portion to be formed. .
なお、場合によっては試料核酸をブライマーとして利用
するものであっても良い。Note that, depending on the case, the sample nucleic acid may be used as a primer.
プローブ核酸の構成としては、例えば5′末端側に固定
化用核酸とハイブリダイズできるB部分を、かつ3′末
端側に被検出核酸とハイブリダイズできるA部分をそれ
ぞれ有し、例えば第1図に示すような各核酸の連結構造
を形成できるものを挙げることができる。The structure of the probe nucleic acid includes, for example, a B portion that can hybridize with the immobilizing nucleic acid at the 5' end, and an A portion that can hybridize with the nucleic acid to be detected at the 3' end. Examples include those that can form a linked structure of each nucleic acid as shown.
固定化用核酸としては、プローブ核酸とハイブリダイズ
できる塩基配列を有し、かっ固相と結合し得る核酸であ
ればどのようなものでも利用できるが、プローブ核酸と
同様に合成機で手軽に合成できるヌクレオチド鎖を有す
るものが利用し易い、この固定化用核酸の鎖長もプロー
ブ核酸の構成やヌクレオチド鎖長を考慮して決定するの
が望ましい。なお、プローブ核酸とハイブリダイズした
固定化用核酸に解離処理を行い固定化用核酸を再利用し
たい場合は、解離操作を考慮した構成を有する固定化用
核酸を用いるとよい。As the nucleic acid for immobilization, any nucleic acid can be used as long as it has a base sequence that can hybridize with the probe nucleic acid and can bind to a solid phase, but it can be easily synthesized using a synthesizer like the probe nucleic acid. The length of the immobilizing nucleic acid is preferably determined by taking into consideration the structure of the probe nucleic acid and the nucleotide chain length. Note that when it is desired to perform a dissociation treatment on the immobilized nucleic acid hybridized with the probe nucleic acid and reuse the immobilized nucleic acid, it is preferable to use an immobilized nucleic acid having a configuration that takes dissociation operations into consideration.
固定化用核酸の固相への固定のための構成としては、後
述する固相に固定化されている物質と選択特異的に結合
する物質を導入した構成が利用できる0例えば、固相に
固定化されている物質としてアビジン、それに選択特異
的に結合し、かつヌクレオチド鎖に結合可能な物質とし
てビオチンがあげられるが、この両物質については選択
特異的に結合し、かつ固定化用核酸のヌクレオチド鎖、
固相に導入できるものであれば、どのようなものでも利
用可能である。As a configuration for immobilizing the nucleic acid for immobilization onto a solid phase, a configuration incorporating a substance that selectively and specifically binds to the substance immobilized on the solid phase described below can be used. Avidin is a substance that selectively binds to avidin, and biotin is a substance that selectively binds to it and is capable of binding to nucleotide chains. chain,
Any material can be used as long as it can be introduced into a solid phase.
試料と、プローブ核酸及び固定化用核酸とのハイブリダ
イゼーションは、常法に従って行なうことができる。Hybridization between a sample, a probe nucleic acid, and a nucleic acid for immobilization can be performed according to a conventional method.
なお、ハイブリッド形成反応の条件は、用いられるプロ
ーブ核酸、固定化用核酸の有するヌクレオチド鎖長や塩
基配列などによって異なるので、ハイブリダイゼーショ
ンにおける操作条件は所望とする目的に応じて最適条件
を適宜選択すると良い。Note that the conditions for the hybridization reaction vary depending on the probe nucleic acid used, the nucleotide chain length and base sequence of the immobilization nucleic acid, so the operating conditions for hybridization should be selected appropriately depending on the desired purpose. good.
このハイブリッド形成反応は、−a的には、ホルムアミ
ド、適当な塩及びDenhardt溶液を含むパイプリ
ダイゼーション溶液中で、温度をコントロールして行う
ことができる。The hybridization reaction can be carried out in a temperature-controlled piperidization solution containing formamide, a suitable salt, and Denhardt's solution.
固定化用核酸の固定化には、固定化用核酸の有する固定
用の特定物質に選択特異的に結合する物質を各種ゲル、
ニトロセルロース等の担体に物理的あるいは化学的に結
合させ、その後選択特異的に結合する物質量に反応を生
じさせる方法が利用できる。For immobilization of nucleic acids for immobilization, various gels,
A method can be used in which the substance is physically or chemically bound to a carrier such as nitrocellulose, and then a reaction is caused in the amount of the substance bound selectively and specifically.
本発明の方法においては、試料とプローブ核酸を反応さ
せ、その結果形成されたハイブリッドに選択的に標識が
施される。In the method of the present invention, a sample and a probe nucleic acid are reacted, and the resulting hybrid is selectively labeled.
この標識化の方法としては、例えばハイブリッドの二本
鎖形成部を構成する鎖の一方をブライマーとして利用し
、その末端を伸展させて1本鎖部分を2本鎖化する際に
、その新たに合成される伸展部分に標識物質を取り込ま
せる方法等が利用できる。As a method for this labeling, for example, one of the strands constituting the double-stranded part of the hybrid is used as a primer, and when the end is extended to make a single-stranded part into a double-stranded part, the new A method of incorporating a labeling substance into the synthesized extended portion can be used.
本発明の方法の上記過程aは、例えば試料とプローブ核
酸とをプローブ核酸のA部分と被検出核酸とでの二本鎖
形成に必要な条件下で反応させた後、得られた反応混合
物に固定化用核酸をプローブ核酸のB部分と固定化用核
酸とでの二本鎖形成に必要な条件で反応させることによ
り行なうことができる。In step a of the method of the present invention, for example, the sample and the probe nucleic acid are reacted under conditions necessary for the formation of a double strand between the A portion of the probe nucleic acid and the nucleic acid to be detected, and then the resulting reaction mixture is This can be carried out by reacting the immobilization nucleic acid with the B portion of the probe nucleic acid and the immobilization nucleic acid under conditions necessary for forming a double strand.
この操作により、試料中に被検出核酸が含まれている場
合には、例えば第1図に示すような被検出核酸ドブロー
ブ核酸2・固定化用核酸3ハイブリツドが形成される。By this operation, when the sample contains the nucleic acid to be detected, a hybrid of the nucleic acid to be detected, the probe nucleic acid 2 and the nucleic acid for immobilization 3, as shown in FIG. 1, for example, is formed.
このハイブリッド形成反応には、試料とプローブ核酸及
び固定化用核酸とを同時にハイブリダイゼーション溶液
中で反応させる方法、試料とプローブ核酸とをハイブリ
ダイゼーションさせ、得られた反応混合物に固定化用核
酸なハイブリダイゼーションさせる方法、プローブ核酸
と固定化用核酸をハイブリダイゼーションさせ、得られ
た反応混合物に試料をハイブリダイゼーションさせる方
法等が利用できる。上記において、固定化用核酸は固相
に固定化されている場合もある。This hybridization reaction includes a method in which a sample is reacted with a probe nucleic acid and a nucleic acid for immobilization simultaneously in a hybridization solution, a method in which a sample and a probe nucleic acid are hybridized, and the resulting reaction mixture is mixed with a nucleic acid for immobilization. A method of hybridization, a method of hybridizing a probe nucleic acid and a nucleic acid for immobilization, and a method of hybridizing a sample to the resulting reaction mixture can be used. In the above, the nucleic acid for immobilization may be immobilized on a solid phase.
すなわち、まずプローブ核酸と固定化用核酸とを反応さ
せ、次いで得られた反応混合物と試料とを反応させても
良い。That is, the probe nucleic acid and the immobilization nucleic acid may be reacted first, and then the obtained reaction mixture and the sample may be reacted.
本発明は、例えば過程aを液相中で行ない、得られた反
応混合物に該反応混合物に含まれる固定化用核酸の固相
への固定に必要な処理を行なうことにより行なうことが
できる。この際、該反応混合液に被検出核酸・プローブ
核酸・固定化用核酸ハイブリッドが形成されている場合
には、このハイブリッドも固定化用核酸を介して固相に
固定され、例えば第2図のような固定相5への固定状態
が得られる。The present invention can be carried out, for example, by carrying out step a in a liquid phase, and subjecting the resulting reaction mixture to the necessary treatments for immobilizing the nucleic acid for immobilization contained in the reaction mixture onto a solid phase. At this time, if a hybrid of the nucleic acid to be detected, the probe nucleic acid, and the nucleic acid for immobilization is formed in the reaction mixture, this hybrid is also immobilized on the solid phase via the nucleic acid for immobilization, for example, as shown in FIG. A state of fixation to the stationary phase 5 can be obtained.
また、固定化用核酸の固相への固定のための処理を、二
本鎖形成のための反応の前に導入することにより行なう
こともできる。その具体的な方法としては、固相に固定
された固定化用核酸に、試料及びプローブ核酸を同時に
反応させる方法、固相に固定された固定化用核酸に、プ
ローブ核酸を反応させ次いで試料を反応させる方法、試
料とプローブ核酸を反応させ、得られた反応混合物を固
相に固定された固定化用核酸と反応させる方法、固定化
用核酸とプローブ核酸を反応させ、得られた固定化用核
酸−プローブ核酸ハイブリッドを固相に固定した後、該
ハイブリッドに試料を反応させる方法がある。Furthermore, a treatment for immobilizing the nucleic acid for immobilization onto a solid phase can also be carried out by introducing the treatment before the reaction for forming double strands. Specific methods include a method in which a sample and a probe nucleic acid are simultaneously reacted with an immobilized nucleic acid immobilized on a solid phase, a method in which a probe nucleic acid is reacted with an immobilized nucleic acid immobilized on a solid phase, and then a sample is reacted with the immobilized nucleic acid. A method for reacting, a method for reacting a sample and a probe nucleic acid, and a method for reacting the resulting reaction mixture with a nucleic acid for immobilization immobilized on a solid phase, a method for reacting a nucleic acid for immobilization with a probe nucleic acid, and a method for reacting the resulting reaction mixture for immobilization. There is a method in which a nucleic acid-probe nucleic acid hybrid is immobilized on a solid phase and then a sample is reacted with the hybrid.
本発明の方法における上記過程すは、例えば被検出核酸
とプローブ核酸とのハイブリッドに選択的に標識を施し
、それを用いた標識に応じた方法で検出することにより
行なうことができる。The above steps in the method of the present invention can be carried out, for example, by selectively labeling a hybrid of a nucleic acid to be detected and a probe nucleic acid, and detecting the hybrid by a method depending on the label.
この標識化には、前述したように二本鎖形成部の一方の
鎖をブライマーとし、他の鎖を鋳型として利用して、ブ
ライマーとなる鎖の端部を伸展させる際に、新たに形成
させる伸展部に標識を取り込ませる方法が利用できる。For this labeling, as mentioned above, one strand of the double-stranded region is used as a brimer, and the other strand is used as a template, and when the end of the strand that will become the brimer is extended, a new strand is formed. A method of incorporating a marker into the extension part can be used.
第2図にプローブ核酸のA部分を構成する3′末端部を
ブライマーとして利用する場合を示す。FIG. 2 shows the case where the 3' end of the probe nucleic acid, which constitutes the A portion, is used as a primer.
具体的には、例久ば、ブライマ一端部の伸展に必要なd
ATP、dCTP、dGTP、dTTPなどのヌクレオ
チドと標識化すべきハイブリッドとをヌクレオチド鎖形
成用の酵素の存在下で反応させ、その際に用いるヌクレ
オチドの1を鋳型に標識化ヌクレオチドを用いて、新た
に形成されるヌクレオチド鎖に標識を取り込ませる方法
等を利用できる。Specifically, for example, d required for extension of one end of the brimer.
A nucleotide such as ATP, dCTP, dGTP, or dTTP is reacted with a hybrid to be labeled in the presence of an enzyme for forming a nucleotide chain, and a labeled nucleotide is used as a template to form a new nucleotide. A method of incorporating a label into the nucleotide chain to be used can be used.
この標識化ヌクレオチドとしては、一般にプローブの標
識に利用されている、例えば放射性同位元素(RI)に
より標識化されたもの、例えばビオチン、ジニトロフェ
ニルヌクレオチド誘導体等の蛍光、発光または発色を誘
発するのに必要な酵素や化合物などの非放射性標識物質
(nonRI)で標識化されたものなどが利用できる。Examples of the labeled nucleotide include those labeled with radioisotopes (RI), which are generally used for labeling probes, such as biotin, dinitrophenyl nucleotide derivatives, etc. that induce fluorescence, luminescence, or color development. Necessary enzymes and compounds labeled with non-radioactive labeling substances (nonRI) can be used.
ヌクレオチド鎖形成用の酵素としては、大腸菌DNAポ
リメラーゼ1%DNAポリメラーゼTのクレノー断片、
T4DNAポリメラーゼ等の各種DNAのポリメラーゼ
や逆転写酵素などが利用できる。As the enzyme for nucleotide chain formation, E. coli DNA polymerase 1% Klenow fragment of DNA polymerase T;
Various DNA polymerases such as T4 DNA polymerase and reverse transcriptase can be used.
本発明における標識化は、ハイブリッドが固定化用核酸
を介して固相に固定化された状態で行なうことができる
。標識化過程を導入する時期としては、被検出核酸とプ
ローブ核酸とがハイブリッドを形成した後に行なうのが
よい。Labeling in the present invention can be performed while the hybrid is immobilized on a solid phase via an immobilization nucleic acid. The labeling process is preferably introduced after the nucleic acid to be detected and the probe nucleic acid form a hybrid.
また、この方法によれば、ハイブリッドを形成していな
い核酸には、新たな二本鎖部分形成のためのブライマー
として機能する部分及び伸展部分形成用の鋳型となる部
分が存在しないので、上記の標識物質を取り込む二本鎖
化反応が生じない。Furthermore, according to this method, a non-hybridized nucleic acid does not have a portion that functions as a primer for forming a new double-stranded portion and a portion that serves as a template for forming an extended portion. A double-stranded reaction that incorporates the labeling substance does not occur.
なお、標識化の反応終了後に、標識化されたハイブリッ
ドと、ハイブリッドに取り込まれなかった標識との分離
は、例えば以下のような方法により行なうことができる
。すなわち固定化用核酸を介して固相に固定されたプロ
ーブ核酸と試料の間にハイブリッドが形成された場合に
は、ハイブリッドも固相に固定化されている状態となる
。その状態で洗浄し、ハイブリッドに取り込まれなかっ
た標識を洗い出して除去する。Note that after the labeling reaction is completed, the labeled hybrid and the label that is not incorporated into the hybrid can be separated, for example, by the following method. That is, when a hybrid is formed between the probe nucleic acid immobilized on the solid phase via the immobilization nucleic acid and the sample, the hybrid is also immobilized on the solid phase. Wash in this state to wash out and remove the label that has not been incorporated into the hybrid.
また、試料、プローブ核酸及び固定化用核酸の反応類を
前述のように種々変更した場合でも、最終的に固定化用
核酸を介したハイブリッドの固相への固定化状態を得た
後、上述と同様の洗浄処理を行なってハイブリッドに取
り込まれなかった標識を分離することができる。In addition, even if the reactions of the sample, probe nucleic acid, and immobilization nucleic acid are variously changed as described above, the above-mentioned method can be applied after the hybrid is finally immobilized on the solid phase via the immobilization nucleic acid. Labels that are not incorporated into the hybrid can be separated by a similar washing process.
ハイブリッドに取り込まれた標識の検出は、例えば第2
図に示すように固相に固定化された状態のハイブリッド
に取り込まれている標識を、該標識に応じた方法で検出
する方法、固相に固定化されたハイブリッドの固定化用
核酸とプローブ核酸との結合部を解離させ、固相から離
された被検出核酸・プローブ核酸ハイブリッドに取り込
まれている標識を該標識に応じた方法で検出方法等によ
り行なうことができる・
なお、本発明の方法においては、固相に固定されたハイ
ブリッドのプローブ核酸と固定化用核酸との結合部を解
離させて得られる固定化用核酸が結合した固相は、次の
検出反応に繰返し再利用可能である。その際、B部分を
再利用する固定化用核酸に対して共通に形成し、A部分
を被検出核酸に応じて異ならせた複数種のプローブ核酸
を用いれば、固相に固定された固定化用核酸を異なる被
検出核酸の検出に繰返し再利用できる。Detection of the label incorporated into the hybrid can be carried out, for example, by the second
As shown in the figure, a method for detecting a label incorporated into a hybrid immobilized on a solid phase using a method according to the label, a nucleic acid for immobilization of a hybrid immobilized on a solid phase, and a probe nucleic acid. The label incorporated into the target nucleic acid/probe nucleic acid hybrid separated from the solid phase can be detected by a detection method, etc. in a manner appropriate for the label. In this method, the solid phase bound to the immobilization nucleic acid obtained by dissociating the bond between the hybrid probe nucleic acid immobilized on the solid phase and the immobilization nucleic acid can be repeatedly reused for the next detection reaction. . At that time, if multiple types of probe nucleic acids are used, in which the B part is formed in common with the immobilization nucleic acid to be reused, and the A part is different depending on the nucleic acid to be detected, it is possible to immobilize the immobilization on the solid phase. The used nucleic acid can be repeatedly reused for the detection of different target nucleic acids.
また、本発明の方法において、ハイブリッドに取り込ま
れた標識の量を測定することにより、被検出核酸の定量
を行なうことができる。Furthermore, in the method of the present invention, the amount of the label incorporated into the hybrid can be measured to quantify the nucleic acid to be detected.
〔実施例1
プラスミドpUc19の塩基配列の一部をもつ遺伝子検
出を行った。[Example 1 A gene having a part of the base sequence of plasmid pUc19 was detected.
プラスミドpuc 19の塩基配列の一部に対応するA
部分と後に述べる固定化用核酸に対して相補的な塩基配
列をもつB部分、及びその間にAとBとの距離を保つ塩
基配列をもった下記の構成のオリゴヌクレオチドをDN
A合成装置(AppliedBiosystems社、
381 A型)により合成しプローブ核酸1とした。A corresponding to part of the base sequence of plasmid puc 19
An oligonucleotide with the following structure, which has a B part with a complementary base sequence to the immobilization nucleic acid described later, and a base sequence that maintains the distance between A and B, is used as a DN.
A synthesis device (Applied Biosystems,
381 A type) and designated as probe nucleic acid 1.
5′
A部分
次に固定化用核酸調製用オリゴヌクレオチドとして、下
記の塩基配列を有するオリゴヌクレオチドをDNA合成
装置で合成した。5' A portion Next, as an oligonucleotide for preparing a nucleic acid for immobilization, an oligonucleotide having the following base sequence was synthesized using a DNA synthesizer.
これらの合成されたオリゴヌクレオチドの一部をサンプ
リングし、7M尿素を含む20%ポリアクリルアミドゲ
ル電気泳動によりその純度を調べた。その結果、95%
以上の純度であったので、それ以上の精製を行なわずに
以下の反応に用いることにした。A portion of these synthesized oligonucleotides was sampled and its purity was examined by electrophoresis on a 20% polyacrylamide gel containing 7M urea. As a result, 95%
Since the purity was above, it was decided to use it in the following reaction without further purification.
更に、上述のようにして得た固定化用核酸調製用オリゴ
ヌクレオチドに以下の操作によりビオチンを導入して固
定化用核酸を得た。Furthermore, biotin was introduced into the oligonucleotide for preparing a nucleic acid for immobilization obtained as described above by the following procedure to obtain a nucleic acid for immobilization.
合成オリゴヌクレオチド50μ℃(50μg)、混合試
薬液((1,46Mカコジル酸カリウム、0.]2MT
ris−OHpH6,9,3,3mMCoC1g、0、
33mMジチオスレイトール)100μJ、4.0mM
ビオチン化UTP (BRL社製)40μβ、1.0m
M dTTP 1u4、H2O100ufiおよび
TdT 15un(約90 unit)を混合し、3
0℃で反応を行なった。10分間経過後、0.2M
EDTA 4μ℃を反応系に添加し、酵素反応を停止
させ、更にフェノール処理、エタノール沈殿を行い得ら
れた沈殿物を乾燥後HaO100LLI2に溶解した。Synthetic oligonucleotide at 50μ℃ (50μg), mixed reagent solution ((1,46M potassium cacodylate, 0.)2MT
ris-OHpH6,9,3,3mMCoC1g,0,
33mM dithiothreitol) 100μJ, 4.0mM
Biotinylated UTP (manufactured by BRL) 40μβ, 1.0m
Mix 1 u4 of M dTTP, 100 ufi of H2O and 15 un (approximately 90 units) of TdT,
The reaction was carried out at 0°C. After 10 minutes, 0.2M
EDTA at 4 μC was added to the reaction system to stop the enzymatic reaction, followed by phenol treatment and ethanol precipitation. The resulting precipitate was dried and dissolved in HaO100LLI2.
次に、試料としてプラスミドpUC19、p13R32
2及びこれらの混合物(1:1)を用意し、各試料を常
法に従いEcoRIで消化してから得られた消化物を加
熱処理して、二本鎖DNAを一本鎖化し、各試料から得
られた3種の一本鎖DNA混合物を個々に用いて以下の
操作を行なった。Next, plasmids pUC19 and p13R32 were used as samples.
2 and a mixture thereof (1:1), each sample was digested with EcoRI according to a conventional method, and the resulting digest was heat-treated to convert double-stranded DNA into single-stranded DNA, and from each sample The following operations were performed using the three types of single-stranded DNA mixtures obtained individually.
一本鎖DNA混合物20μgと、先に調製した固定化用
核酸2μg及びプローブ核酸2μgを試験管に入れIO
Xアニーリング溶液(100mMTr i 5−HCl
pH8,0,60mMMgC1□、60mM β
−メルカプトエタノール、500mM NaC1)を
10u12を加え、更に蒸留水を加え全体が100μi
になるように調製した。得られた溶液を65℃まで加熱
し、10分間その温度を保った後約1時間かけてゆっく
り室温まで冷ました。この時の反応状態を模式的に示し
たのが第2図である。Put 20 μg of the single-stranded DNA mixture, 2 μg of the previously prepared immobilization nucleic acid, and 2 μg of probe nucleic acid into a test tube, and add IO.
X annealing solution (100mM Tri 5-HCl
pH8, 0, 60mM MgC1□, 60mM β
-Add 10u12 of mercaptoethanol, 500mM NaCl), and then add distilled water to make the whole 100μi
It was prepared so that The resulting solution was heated to 65°C, maintained at that temperature for 10 minutes, and then slowly cooled to room temperature over about 1 hour. FIG. 2 schematically shows the reaction state at this time.
次に、得られた反応液100μiにIOXアニーリング
溶液10LL(1,1mM dATP、1mMdCT
P及び1 mM d G T Pを各107.tn加
えた後、p”−TTP 100uAを添加シ、サラニ
蒸留水を加え全液量を200μρとして標識化用の溶液
を調製した。この溶液にDNAポリメラーゼIのKle
now断片を5単位加え水冷下で1時間反応させた。こ
の時の状態を模式的に示したのが第3図である。Next, 10 LL of IOX annealing solution (1,1mM dATP, 1mM dCT
P and 1 mM dG T P at 107% each. After adding tn, 100 uA of p"-TTP was added, and Sarani distilled water was added to make the total volume 200 μρ to prepare a labeling solution. To this solution, Kle of DNA polymerase I was added.
Five units of the now fragment were added and reacted for 1 hour under water cooling. FIG. 3 schematically shows the state at this time.
反応後、この反応液を7ガロースゲルを臭化シアンで活
性化しアビジンを結合した固相と混合し、20分間ゆっ
くり混和させた後、常温で軽く遠心し上清を廃棄した。After the reaction, this reaction solution was mixed with a solid phase in which 7-garose gel was activated with cyanogen bromide and avidin was bound thereto. After being mixed slowly for 20 minutes, the mixture was briefly centrifuged at room temperature and the supernatant was discarded.
得られた沈殿物をTE緩衝液で2度洗浄した後その放射
線の計数をシンチレーションカウンターで数度測定した
ところpuc l 9及びpUc19とpBR322の
混合物を用いた場合は10’〜’cpmの強度が計数さ
れ、pBR322のみの試料におけるその値はバックグ
ランドの2倍に満たなかった。The resulting precipitate was washed twice with TE buffer and the radiation counts were measured several times using a scintillation counter. When a mixture of puc l 9 and pUc19 and pBR322 was used, the intensity was 10' to ' cpm. The value in the pBR322-only sample was less than twice background.
また、上記沈殿物をTE緩衝液に加え、80℃で10分
間加熱を行なった後すばやく遠心し上清を廃棄した後、
沈殿物をTE緩衝液で洗浄して放射活性を測定した。そ
の結果、沈殿物中に放射活性は計量されず、この加熱処
理により標識を取り込んだ部分が解離されたことが確認
された。In addition, the above precipitate was added to TE buffer, heated at 80°C for 10 minutes, quickly centrifuged, and the supernatant was discarded.
The precipitate was washed with TE buffer and radioactivity was measured. As a result, no radioactivity was detected in the precipitate, confirming that the label-incorporated portion was dissociated by this heat treatment.
次に、この加熱処理後に得られた沈殿物を、上述と同様
の操作に再利用したところ、良好な核酸の操作が行なえ
た。従って、該沈殿物はアビジンビオチン結合により固
定化用核酸が臭化シアン活性化アガロースに結合したも
のであり、繰返し再利用が可能であることが確認された
。Next, when the precipitate obtained after this heat treatment was reused in the same operation as described above, the nucleic acid could be successfully manipulated. Therefore, it was confirmed that the precipitate was one in which the nucleic acid for immobilization was bound to cyanogen bromide-activated agarose through avidin-biotin binding, and that it could be repeatedly reused.
[発明の効果]
従来、検出を行なう目的遺伝子の塩基配列に応じて核酸
断片を用意し、これを固定化プローブとして用いるため
に、固定化の処理を施す必要があった。[Effects of the Invention] Conventionally, in order to prepare a nucleic acid fragment according to the base sequence of the target gene to be detected and use it as an immobilized probe, it was necessary to perform an immobilization process.
また、検出したい遺伝子の種類が変われば、それに従っ
て新たな核酸断片を用意し、なおかつ、これに固定化の
処理が必要となる。つまり検出する遺伝子が変わるたび
に、それに応じて固定化プローブを形成する必要がある
。Furthermore, if the type of gene to be detected changes, it is necessary to prepare new nucleic acid fragments accordingly and to immobilize them. In other words, each time the gene to be detected changes, it is necessary to form an immobilized probe accordingly.
しかし本発明では固定化用プローブとその一部と相補的
配列をもつプローブ核酸を用いることによって検出した
い遺伝子核酸の種類が変ってもプローブ核酸のみを作成
すればよく、固相への固定化の処理を行なう必要が全く
ないので、迅速かつ簡便な核酸の検出を行なうことがで
きる。However, in the present invention, by using an immobilization probe and a probe nucleic acid having a complementary sequence to a part of the immobilization probe, even if the type of gene nucleic acid to be detected changes, only the probe nucleic acid needs to be prepared. Since there is no need for any treatment, nucleic acids can be detected quickly and easily.
また、本発明においては標識を取り込んだハイブリッド
と取り込まれなかった標識との分離が固相・液相間で精
度良く行なわれるので、精度良い検出操作が可能となる
。Furthermore, in the present invention, since the hybrid into which the label has been incorporated and the label which has not been incorporated are accurately separated between the solid phase and the liquid phase, accurate detection operations are possible.
更に、本発明においては、アビジン−ビオチン結合等を
利用して固相に結合させた固定化用核酸は、プローブ核
酸との解離処理を行なうことにより再利用可能である。Furthermore, in the present invention, the immobilized nucleic acid bound to a solid phase using an avidin-biotin bond or the like can be reused by performing a dissociation treatment from the probe nucleic acid.
従って、この固相に結合された固定化用核酸を利用する
ことにより、新たな検出操作において化学的反応等を利
用した固相への核酸の結合処理を省略でき、操作が極め
て簡易化される。Therefore, by using the immobilized nucleic acid bound to this solid phase, it is possible to omit the process of binding the nucleic acid to the solid phase using a chemical reaction etc. in a new detection operation, and the operation is extremely simplified. .
第1図は被検出核酸・プローブ核酸・固定化用核酸ハイ
ブリッドの構成を示す模式図、第2図は第1図で示した
ハイブリッドな固相に固定した状態を示す模式図、第3
図は第2図で示した固定化ハイブリッド標識化の過程を
示す模式図である。
1:被検出核酸 2ニブローブ核酸3:固定化用
核酸 4:標識
5:固相Figure 1 is a schematic diagram showing the configuration of a nucleic acid to be detected, a probe nucleic acid, and a nucleic acid hybrid for immobilization. Figure 2 is a schematic diagram showing the state immobilized on the hybrid solid phase shown in Figure 1.
The figure is a schematic diagram showing the process of immobilized hybrid labeling shown in FIG. 2. 1: Nucleic acid to be detected 2 Niprobe nucleic acid 3: Nucleic acid for immobilization 4: Label 5: Solid phase
Claims (1)
ズする部分とを有する固定化用核酸を用い、 a)被検出核酸・プローブ核酸・固定化核酸ハイブリッ
ドを形成する過程と、 b)固相に結合されたハイブリッドを標識を利用して被
検出核酸・プローブ核酸ハイブリッドの形成の有無を検
出する過程と を含むことを特徴とする核酸の検出方法。 2)被検出核酸とプローブ核酸との二本鎖形成部に選択
的に標識を施す請求項1に記載の核酸の検出方法。 3)被検出核酸、プローブ核酸及び固定化用核酸を同時
に反応させる請求項1に記載の核酸の検出方法。 4)被検出核酸とプローブ核酸を反応させ、得られた反
応混合物に固定化用核酸を反応させる請求項1に記載の
核酸の検出方法。 5)プローブ核酸と固定化用核酸とを反応させ、得られ
た反応混合物に被検出核酸を反応させる請求項1に記載
の核酸の検出方法。 6)被検出核酸・プローブ核酸ハイブリッドを固定化用
核酸より解離する過程を有する請求項1記載の核酸の検
出方法。[Claims] 1) Using a sample containing a nucleic acid to be detected, a probe nucleic acid, a nucleic acid for immobilization having a portion bound to a solid phase, and a portion hybridizing with the probe nucleic acid, a) a nucleic acid to be detected; a step of forming a nucleic acid/probe nucleic acid/immobilized nucleic acid hybrid; and b) a step of detecting the presence or absence of formation of a target nucleic acid/probe nucleic acid hybrid by using a label on the hybrid bound to a solid phase. Characteristic nucleic acid detection method. 2) The method for detecting a nucleic acid according to claim 1, wherein a double-stranded region between the nucleic acid to be detected and the probe nucleic acid is selectively labeled. 3) The method for detecting a nucleic acid according to claim 1, wherein the nucleic acid to be detected, the probe nucleic acid, and the nucleic acid for immobilization are reacted simultaneously. 4) The method for detecting a nucleic acid according to claim 1, wherein the nucleic acid to be detected and the probe nucleic acid are reacted, and the resulting reaction mixture is reacted with the nucleic acid for immobilization. 5) The method for detecting a nucleic acid according to claim 1, wherein the probe nucleic acid and the nucleic acid for immobilization are reacted, and the resulting reaction mixture is reacted with the nucleic acid to be detected. 6) The method for detecting a nucleic acid according to claim 1, comprising the step of dissociating the nucleic acid to be detected/probe nucleic acid hybrid from the immobilized nucleic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29155889A JPH03151900A (en) | 1989-11-09 | 1989-11-09 | Method for detecting nucleic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29155889A JPH03151900A (en) | 1989-11-09 | 1989-11-09 | Method for detecting nucleic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03151900A true JPH03151900A (en) | 1991-06-28 |
Family
ID=17770475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29155889A Pending JPH03151900A (en) | 1989-11-09 | 1989-11-09 | Method for detecting nucleic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03151900A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893822B2 (en) | 2001-07-19 | 2005-05-17 | Nanogen Recognomics Gmbh | Enzymatic modification of a nucleic acid-synthetic binding unit conjugate |
JP2017169449A (en) * | 2016-03-18 | 2017-09-28 | 株式会社東芝 | Method for detecting nucleic acid |
-
1989
- 1989-11-09 JP JP29155889A patent/JPH03151900A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893822B2 (en) | 2001-07-19 | 2005-05-17 | Nanogen Recognomics Gmbh | Enzymatic modification of a nucleic acid-synthetic binding unit conjugate |
EP2298929A1 (en) * | 2001-07-19 | 2011-03-23 | Nanogen Recognomics GmbH | Sorting and immobilization system for nucleic acids using synthetic binding systems |
JP2017169449A (en) * | 2016-03-18 | 2017-09-28 | 株式会社東芝 | Method for detecting nucleic acid |
US10876153B2 (en) | 2016-03-18 | 2020-12-29 | Kabushiki Kaisha Toshiba | Nucleic acid detection method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5830643A (en) | Partially double-stranded oligonucleotide and method for forming oligonucleotide | |
JP3021036B2 (en) | Detection of nucleic acid sequences or changes therein | |
EP0297379B1 (en) | Method for amplifying genes | |
EP0875583B1 (en) | Primers and kits for the detection of Chlamydia trachomatis | |
JP2846018B2 (en) | Amplification and detection of nucleic acid sequences | |
EP0374665A2 (en) | Assay of sequences using amplified genes | |
Ganguly et al. | Detection of single-base mutations by reaction of DNA heteroduplexes with a water-soluble carbodiimide followed by primer extension: application to products from the polymerase chain reaction | |
AU5345790A (en) | Process for nucleic acid detection by binary amplification | |
KR20010111020A (en) | Isometric primer extension method and kit for detection and quantification of specific nucleic acid | |
Dicker et al. | Mutational analysis of human NRAS genes in malignant melanoma: rapid methods for oligonucleotide hybridization and manual and automated direct sequencing of products generated by the polymerase chain reaction | |
JP2002533097A (en) | Detection of specific nucleic acid sequences by polymerase nucleotide incorporation | |
JPH03151900A (en) | Method for detecting nucleic acid | |
Lyons | The polymerase chain reaction and cancer diagnostics | |
Warren et al. | Detection of mutations by single‐strand conformation polymorphism (SSCP) analysis and SSCP‐hybrid methods | |
Thompson et al. | Current concepts in quantitative molecular hybridization | |
JPS62143700A (en) | Nucleic acid assay by pairing segment control or competition | |
EP0421469B1 (en) | Method for separating a target oligonucleotide | |
JPH01252300A (en) | Detection of aimed nucleic acid in specimen | |
JPH03210197A (en) | Preparation of fluorescence-labelled dna and kit therefor | |
JP3103806B1 (en) | Nucleic acid detection method | |
JP2001518787A (en) | Nucleic acid hybridization detection system and its preparation and application | |
AU723602B2 (en) | Biotin-labelled DNA by polymerase chain reaction and detection thereof | |
JPH05192198A (en) | Detection of nucleic acid | |
Chan et al. | Production and use of nonradioactive hybridization probes | |
JPH04197200A (en) | Method of detecting nucleic acid |